Literature DB >> 23361104

Intracellular drug concentrations.

C T Dollery1.   

Abstract

Many drug targets are intracellular. To access them, a drug molecule must pass through the cell membrane, a process often facilitated or impeded by transporters. Once in the cytoplasm, basic molecules may become concentrated in organelles. To predict the pharmacologic effect accurately, there must be data concerning the concentration at the target, which is difficult to measure. Techniques that combine mass spectrometry and imaging techniques (matrix-assisted laser desorption/ionization, secondary ion mass spectrometry (SIMS), and nanoSIMS) have promise in addressing this problem.

Mesh:

Substances:

Year:  2012        PMID: 23361104     DOI: 10.1038/clpt.2012.240

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  20 in total

Review 1.  Uptake carriers and oncology drug safety.

Authors:  Jason A Sprowl; Alex Sparreboom
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

2.  Characterization of binding of raltegravir to plasma proteins.

Authors:  Caroline Barau; Valérie Furlan; Yazdan Yazdanpanah; Catherine Fagard; Jean-Michel Molina; Anne-Marie Taburet; Aurélie Barrail-Tran
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

3.  Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.

Authors:  Nathan D Pfeifer; Kevin B Harris; Grace Zhixia Yan; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-08-29       Impact factor: 3.922

Review 4.  Visualization of metallodrugs in single cells by secondary ion mass spectrometry imaging.

Authors:  Kui Wu; Feifei Jia; Wei Zheng; Qun Luo; Yao Zhao; Fuyi Wang
Journal:  J Biol Inorg Chem       Date:  2017-05-15       Impact factor: 3.358

5.  Translocation of small molecules through engineered outer-membrane channels from Gram-negative bacteria.

Authors:  Rémi Terrasse; Mathias Winterhalter
Journal:  Eur Phys J E Soft Matter       Date:  2018-09-24       Impact factor: 1.890

6.  Analysis of Chemotherapeutic Drug Delivery at the Single Cell Level Using 3D-MSI-TOF-SIMS.

Authors:  Quentin P Vanbellingen; Anthony Castellanos; Monica Rodriguez-Silva; Iru Paudel; Jeremy W Chambers; Francisco A Fernandez-Lima
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-31       Impact factor: 3.109

7.  The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power.

Authors:  Melissa K Passarelli; Alexander Pirkl; Rudolf Moellers; Dmitry Grinfeld; Felix Kollmer; Rasmus Havelund; Carla F Newman; Peter S Marshall; Henrik Arlinghaus; Morgan R Alexander; Andy West; Stevan Horning; Ewald Niehuis; Alexander Makarov; Colin T Dollery; Ian S Gilmore
Journal:  Nat Methods       Date:  2017-11-13       Impact factor: 28.547

8.  Analysis of liposome model systems by time-of-flight secondary ion mass spectrometry.

Authors:  Jelena Lovrić; Jacqueline D Keighron; Tina B Angerer; Xianchan Li; Per Malmberg; John S Fletcher; Andrew G Ewing
Journal:  Surf Interface Anal       Date:  2014-11       Impact factor: 1.607

9.  Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.

Authors:  Priyanka Kulkarni; Kenneth Korzekwa; Swati Nagar
Journal:  J Pharmacol Exp Ther       Date:  2016-07-22       Impact factor: 4.030

Review 10.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-08-09       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.